Bioelectric Medicine Market Report by Type (Implantable Electroceutical Devices, Non-Invasive Electroceutical Devices), Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulator

Bioelectric Medicine Market Report by Type (Implantable Electroceutical Devices, Non-Invasive Electroceutical Devices), Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others), Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Parkinson’s Disease, Tremor, Depression, Treatment-Resistant Depression, Epilepsy, Urinary and Fecal Incontinence, and Others), End Use (Hospitals, Research Institutes, Individual Users, and Others), and Region 2024-2032


The global bioelectric medicine market size reached US$ 22.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 35.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.15% during 2024-2032.

Bioelectric medicine or electroceuticals encompasses medical-related devices that utilize electrical impulses and signaling in the nervous system. It combines molecular medicine, neuroscience, and bioengineering to develop nerve-stimulating technologies for biological processes during the treatment of diseases. It consists of cochlear, retinal implants, relief, cardiac pacemakers, spinal cord stimulators, and implantable defibrillators. Bioelectric medicine includes tiny electronic implants that can diagnose and treat various chronic diseases, such as rheumatoid arthritis, inflammatory bowel disease, cancer, obesity, diabetes, asthma, paralysis, and cardiovascular diseases (CVDs). It can treat a wide range of conditions and disorders using both non-invasive and invasive approaches.

Bioelectric Medicine Market Trends:

The growing geriatric population and the increasing incidences of cardiovascular and neurological disorders across the globe are creating a positive outlook for the market. Bioelectric medicine uses the deep brain, vagus sacral, and transcutaneous electric nerve stimulator to treat these conditions. In line with this, the escalating prevalence of arrhythmia that involves the use of implantable cardioverter-defibrillators and cardiac pacemakers to treat the ailment is acting as another growth-inducing factor. Additionally, the increasing demand for deep brain stimulators owing to the rising instances of Parkinson's disease and lifestyle-induced disorders, such as depression and obesity, is favoring the market growth. Apart from this, manufacturers are launching smart products that help in the early detection and diagnosis of cardiac arrhythmias and cater unmet needs of the consumers, which, in turn, is providing an impetus to the market growth. Moreover, increasing approvals for advanced bioelectric medicine and a rise in investment and funding of new therapies and electroceuticals are positively influencing the market growth. Besides this, extensive research and development (R&D) activities, significant growth in the healthcare infrastructure, increasing expenditure capacities of consumers, and the presence of advanced medical devices for treatment purposes are supporting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bioelectric medicine market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product, application and end use.

Breakup by Type:
  • mplantable Electroceutical Devices
  • Non-Invasive Electroceutical Devices
Breakup by Product:
  • mplantable Cardioverter Defibrillators
  • Cardiac Pacemakers
  • Cochlear Implants
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Transcutaneous Electrical Nerve Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others
Breakup by Application:
  • Arrhythmia
  • Pain Management
  • Sensorineural Hearing Loss
  • Parkinson’s Disease
  • Tremor
  • Depression
  • Treatment-Resistant Depression
  • Epilepsy
  • Urinary and Fecal Incontinence
  • Others
Breakup by End Use:
  • Hospitals
  • Research Institutes
  • ndividual Users
  • Others
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Biotronik SE & Co KG, Boston Scientific Corporation, Cochlear Limited, electroCore Inc., LivaNova PLC, MED-EL Medical Electronics, Medtronic plc and Sonova Holding AG.

Key Questions Answered in This Report

1. How big is the global bioelectric medicine market?

2. What is the expected growth rate of the global bioelectric medicine market during 2024-2032?

3. What are the key factors driving the global bioelectric medicine market?

4. What has been the impact of COVID-19 on the global bioelectric medicine market?

5. What is the breakup of the global bioelectric medicine market based on the type?

6. What is the breakup of the global bioelectric medicine market based on the product?

7. What is the breakup of the global bioelectric medicine market based on the application?

8. What is the breakup of the global bioelectric medicine market based on the end use?

9. What are the key regions in the global bioelectric medicine market?

10. Who are the key players/companies in the global bioelectric medicine market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bioelectric Medicine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Implantable Electroceutical Devices
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Non-Invasive Electroceutical Devices
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product
7.1 Implantable Cardioverter Defibrillators
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiac Pacemakers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cochlear Implants
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Spinal Cord Stimulators
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Deep Brain Stimulators
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Transcutaneous Electrical Nerve Stimulators
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Sacral Nerve Stimulators
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Vagus Nerve Stimulators
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Application
8.1 Arrhythmia
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pain Management
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Sensorineural Hearing Loss
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Parkinson’s Disease
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Tremor
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Depression
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Treatment-Resistant Depression
8.7.1 Market Trends
8.7.2 Market Forecast
8.8 Epilepsy
8.8.1 Market Trends
8.8.2 Market Forecast
8.9 Urinary and Fecal Incontinence
8.9.1 Market Trends
8.9.2 Market Forecast
8.10 Others
8.10.1 Market Trends
8.10.2 Market Forecast
9 Market Breakup by End Use
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Individual Users
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Biotronik SE & Co KG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 SWOT Analysis
15.3.3 Boston Scientific Corporation
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Cochlear Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 electroCore Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 LivaNova PLC
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.7 MED-EL Medical Electronics
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Medtronic plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Sonova Holding AG
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings